Asymchem funding history / development milestones

战略投资，23亿人民币

2020.02.18, 高瓴资本

IPO上市，主板

2016.11.18，深交所

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

生命科学

药物研发

生物医药

新药研发

原料药

制药/药业

医药原料

CRO

CMC

创新药

CDMO

多肽

中间体

抗癌药物

化工原料

People who follow Asymchem also follow

Asymchem Competitors (Similar Companies)

Follow in Bulk Copy Company Names

Novo Nordisk (China) Pharmaceuticals Co., Ltd.

“A leader in the diabetes field”

Aima Technology Group Co., Ltd.

“Fashion Aima, free travel”

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

“Research, development, and production of anti-tumor and surgical medic”

Tasly Pharmaceutical Group Co., Ltd.

“A landmark enterprise in the modernization of traditional Chinese medi”

上海凯莱英生物技术有限公司

医药生命科学药物研发医药中间体

CanSino Biologics Inc.

“R&D, production and commercialization of high-quality human vaccines”

Pharmaceutical Research Associates, Inc. (Pharmaron Beijing) Co., Ltd.

“Helping partners successfully develop new drugs, reducing R&D costs an”

Innovent Biologics (Suzhou) Co., Ltd.

“To develop high-quality biologics that are accessible and affordable f”

Pfizer Investment Co., Ltd.

“Continuously innovating to bring patients medicines that significantly”

WuXi AppTec Co., Ltd.

“Making drugs and cures accessible to all”

China Automotive Technology and Research Center Co., Ltd.

汽车工业咨询智能辅助驾驶研发

Ringpu Biology Co., Ltd.

“A listed company focusing on the veterinary drug sector”

Shanghai PharmaTech Co., Ltd.

“A leading open-access capability and technology platform company for p”

Wuxi WuXi Biologics Co., Ltd.

“Accelerating global biologic drug R&D processes, reducing R&D costs, a”

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

“A renowned enterprise in China's liver disease and anti-tumor fields”

中 中文版 View this page in Chinese ›